HUE026151T2 - A method for characterizing the biological activity of anthrax eggs, especially Trichuris eggs - Google Patents
A method for characterizing the biological activity of anthrax eggs, especially Trichuris eggs Download PDFInfo
- Publication number
- HUE026151T2 HUE026151T2 HUE09769081A HUE09769081A HUE026151T2 HU E026151 T2 HUE026151 T2 HU E026151T2 HU E09769081 A HUE09769081 A HU E09769081A HU E09769081 A HUE09769081 A HU E09769081A HU E026151 T2 HUE026151 T2 HU E026151T2
- Authority
- HU
- Hungary
- Prior art keywords
- eggs
- larvae
- egg
- determination
- test
- Prior art date
Links
- 235000013601 eggs Nutrition 0.000 title claims description 198
- 238000000034 method Methods 0.000 title claims description 85
- 241001489151 Trichuris Species 0.000 title claims description 12
- 230000004071 biological effect Effects 0.000 title description 33
- 238000012360 testing method Methods 0.000 claims description 50
- 230000004899 motility Effects 0.000 claims description 38
- 238000004458 analytical method Methods 0.000 claims description 29
- 239000000523 sample Substances 0.000 claims description 26
- 241001465754 Metazoa Species 0.000 claims description 21
- 210000000936 intestine Anatomy 0.000 claims description 18
- 238000005259 measurement Methods 0.000 claims description 18
- 238000010171 animal model Methods 0.000 claims description 12
- 230000002503 metabolic effect Effects 0.000 claims description 9
- 239000007850 fluorescent dye Substances 0.000 claims description 7
- 241000282887 Suidae Species 0.000 claims description 6
- 230000000968 intestinal effect Effects 0.000 claims description 6
- 238000011533 pre-incubation Methods 0.000 claims description 6
- 238000003753 real-time PCR Methods 0.000 claims description 6
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 5
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 5
- 238000009396 hybridization Methods 0.000 claims description 4
- 230000006698 induction Effects 0.000 claims description 4
- 239000003550 marker Substances 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 238000010170 biological method Methods 0.000 claims description 3
- 238000000684 flow cytometry Methods 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 108091005804 Peptidases Proteins 0.000 claims description 2
- 239000004365 Protease Substances 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 238000002203 pretreatment Methods 0.000 claims description 2
- 210000001161 mammalian embryo Anatomy 0.000 claims 2
- 235000016623 Fragaria vesca Nutrition 0.000 claims 1
- 240000009088 Fragaria x ananassa Species 0.000 claims 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 238000012512 characterization method Methods 0.000 claims 1
- 239000003086 colorant Substances 0.000 claims 1
- 235000015114 espresso Nutrition 0.000 claims 1
- 210000003736 gastrointestinal content Anatomy 0.000 claims 1
- 230000000762 glandular Effects 0.000 claims 1
- 210000003254 palate Anatomy 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 235000011888 snacks Nutrition 0.000 claims 1
- 239000004071 soot Substances 0.000 claims 1
- 238000010200 validation analysis Methods 0.000 claims 1
- 239000002023 wood Substances 0.000 claims 1
- 244000000013 helminth Species 0.000 description 41
- 108010034145 Helminth Proteins Proteins 0.000 description 37
- 230000000694 effects Effects 0.000 description 34
- 230000012447 hatching Effects 0.000 description 28
- 108090000623 proteins and genes Proteins 0.000 description 27
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 25
- 238000002360 preparation method Methods 0.000 description 16
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 15
- 230000014509 gene expression Effects 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- 208000015181 infectious disease Diseases 0.000 description 13
- 230000004913 activation Effects 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 11
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 10
- 230000035899 viability Effects 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 230000013020 embryo development Effects 0.000 description 8
- 238000000338 in vitro Methods 0.000 description 8
- 210000004379 membrane Anatomy 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- 238000004020 luminiscence type Methods 0.000 description 7
- 239000000825 pharmaceutical preparation Substances 0.000 description 7
- 241000960389 Trichuris suis Species 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 229940127557 pharmaceutical product Drugs 0.000 description 6
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 229960005305 adenosine Drugs 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 210000003608 fece Anatomy 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000035939 shock Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 241000244188 Ascaris suum Species 0.000 description 3
- 208000023275 Autoimmune disease Diseases 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 208000014837 parasitic helminthiasis infectious disease Diseases 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 230000000392 somatic effect Effects 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 208000011231 Crohn disease Diseases 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 208000006968 Helminthiasis Diseases 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 235000013405 beer Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 210000003278 egg shell Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000000799 fluorescence microscopy Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 208000028774 intestinal disease Diseases 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 230000007653 larval development Effects 0.000 description 2
- 229940126601 medicinal product Drugs 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 150000007523 nucleic acids Chemical group 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 210000001082 somatic cell Anatomy 0.000 description 2
- 238000007447 staining method Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 125000003831 tetrazolyl group Chemical group 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- ZQDAIIUFJKGWON-LBPRGKRZSA-N 5-[(2s)-2-(pyridin-3-yloxymethyl)pyrrolidin-1-yl]sulfonyl-1h-indole-2,3-dione Chemical group C([C@@H]1CCCN1S(=O)(=O)C1=CC=C2NC(C(C2=C1)=O)=O)OC1=CC=CN=C1 ZQDAIIUFJKGWON-LBPRGKRZSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 241000252983 Caecum Species 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 244000089742 Citrus aurantifolia Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 235000017274 Diospyros sandwicensis Nutrition 0.000 description 1
- 244000287680 Garcinia dulcis Species 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 108091023242 Internal transcribed spacer Proteins 0.000 description 1
- 241000282838 Lama Species 0.000 description 1
- 241000254158 Lampyridae Species 0.000 description 1
- 241000272168 Laridae Species 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 101150034459 Parpbp gene Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 101100056293 Rattus norvegicus Akr7a2 gene Proteins 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 241001489145 Trichuris trichiura Species 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- XMQFTWRPUQYINF-UHFFFAOYSA-N bensulfuron-methyl Chemical compound COC(=O)C1=CC=CC=C1CS(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 XMQFTWRPUQYINF-UHFFFAOYSA-N 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 210000004534 cecum Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000010359 gene isolation Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000007431 microscopic evaluation Methods 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 231100000255 pathogenic effect Toxicity 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5029—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell motility
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
- G01N2333/43526—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08009344A EP2123774A1 (de) | 2008-05-21 | 2008-05-21 | Verfahren zur Charakterisierung der biologischen Aktivität von Helminth-Eiern |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE026151T2 true HUE026151T2 (en) | 2016-05-30 |
Family
ID=39768691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE09769081A HUE026151T2 (en) | 2008-05-21 | 2009-05-20 | A method for characterizing the biological activity of anthrax eggs, especially Trichuris eggs |
Country Status (17)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2492637C2 (ru) * | 2011-07-26 | 2013-09-20 | Закрытое акционерное общество "АЛЬФА-ТЭК" | Способ предынкубационной обработки яиц препаратом галосепт |
| US9224200B2 (en) | 2012-04-27 | 2015-12-29 | Parasite Technologies A/S | Computer vision based method for extracting features relating to the developmental stages of Trichuris spp. eggs |
| RU2609145C2 (ru) * | 2015-06-08 | 2017-01-30 | ФАНО России Федеральное государственное бюджетное научное учреждение Всероссийский научно-исследовательский институт фундаментальной и прикладной паразитологии животных и растений им. К.И. Скрябина (ФГБНУ "ВНИИП им. К.И. Скрябина") | Способ сбора максимального количества зрелых (=оплодотворённых) яиц (in vitro) от самок возбудителя паразитарного зооноза trichuris (=trichocephalus) suis |
| US9603875B1 (en) | 2016-01-07 | 2017-03-28 | NeuOva, LLC | Method of making a consumable product with purified embryonated Trichuris suis ova |
| JP6231709B1 (ja) * | 2016-05-31 | 2017-11-15 | シスメックス株式会社 | 蛍光画像分析装置および分析方法 |
| CN106689063B (zh) * | 2016-12-07 | 2020-03-17 | 中国科学院动物研究所 | 一种稻螟赤眼蜂的人工繁育生产方法 |
| WO2025259635A1 (en) * | 2024-06-10 | 2025-12-18 | Parasight System Inc. | Methods for analyzing fecal matter using fluorochromes that covalently bond to parasitic material |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU740776B2 (en) | 1997-12-31 | 2001-11-15 | University Of Iowa Research Foundation, The | Use of parasitic biological agents for prevention and control of autoimmune diseases |
| US7083911B2 (en) * | 2001-02-16 | 2006-08-01 | Promega Corporation | Method for detection of ATP |
| PL1968618T3 (pl) * | 2005-12-30 | 2017-10-31 | Parasite Tech A/S | Kompozycja zawierająca jaja pasożytów oraz sposoby izolowania i przechowywania jaj pasożytów |
| DE102006023906A1 (de) * | 2006-05-19 | 2007-11-22 | Ovamed Gmbh | Verfahren zum Nachweis der Viabilität |
-
2008
- 2008-05-21 EP EP08009344A patent/EP2123774A1/de not_active Withdrawn
-
2009
- 2009-05-20 WO PCT/EP2009/056106 patent/WO2009156232A1/de not_active Ceased
- 2009-05-20 AU AU2009262381A patent/AU2009262381B2/en not_active Ceased
- 2009-05-20 PT PT97690812T patent/PT2279264E/pt unknown
- 2009-05-20 CA CA2723402A patent/CA2723402C/en not_active Expired - Fee Related
- 2009-05-20 HU HUE09769081A patent/HUE026151T2/en unknown
- 2009-05-20 US US12/993,517 patent/US8993332B2/en not_active Expired - Fee Related
- 2009-05-20 RU RU2010152016/10A patent/RU2540145C2/ru not_active IP Right Cessation
- 2009-05-20 JP JP2011509973A patent/JP5753778B2/ja not_active Expired - Fee Related
- 2009-05-20 HR HRP20151173TT patent/HRP20151173T1/hr unknown
- 2009-05-20 UA UAA201015255A patent/UA103769C2/ru unknown
- 2009-05-20 DK DK09769081.2T patent/DK2279264T3/en active
- 2009-05-20 EP EP09769081.2A patent/EP2279264B1/de active Active
- 2009-05-20 CN CN200980118522.9A patent/CN102037141B/zh not_active Expired - Fee Related
- 2009-05-20 SI SI200931292T patent/SI2279264T1/sl unknown
- 2009-05-20 ES ES09769081.2T patent/ES2552356T3/es active Active
- 2009-05-20 PL PL09769081T patent/PL2279264T3/pl unknown
-
2015
- 2015-11-13 CY CY20151101026T patent/CY1116916T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20151173T1 (hr) | 2015-12-04 |
| EP2123774A1 (de) | 2009-11-25 |
| JP2011523847A (ja) | 2011-08-25 |
| WO2009156232A9 (de) | 2010-02-18 |
| US20120060229A9 (en) | 2012-03-08 |
| CN102037141B (zh) | 2014-02-26 |
| CA2723402C (en) | 2018-06-19 |
| UA103769C2 (ru) | 2013-11-25 |
| US8993332B2 (en) | 2015-03-31 |
| AU2009262381A1 (en) | 2009-12-30 |
| HK1147113A1 (en) | 2011-07-29 |
| CY1116916T1 (el) | 2017-04-05 |
| ES2552356T3 (es) | 2015-11-27 |
| DK2279264T3 (en) | 2015-11-23 |
| EP2279264B1 (de) | 2015-08-19 |
| PL2279264T3 (pl) | 2016-01-29 |
| RU2010152016A (ru) | 2012-06-27 |
| CA2723402A1 (en) | 2009-12-30 |
| EP2279264A1 (de) | 2011-02-02 |
| PT2279264E (pt) | 2015-11-20 |
| RU2540145C2 (ru) | 2015-02-10 |
| SI2279264T1 (sl) | 2015-11-30 |
| WO2009156232A1 (de) | 2009-12-30 |
| CN102037141A (zh) | 2011-04-27 |
| US20110191869A1 (en) | 2011-08-04 |
| JP5753778B2 (ja) | 2015-07-22 |
| AU2009262381B2 (en) | 2015-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250346947A1 (en) | Multiplexed single molecule rna visualization with a two-probe proximity ligation system | |
| Stout et al. | Coronaviruses in cats and other companion animals: Where does SARS-CoV-2/COVID-19 fit? | |
| CN110468237B (zh) | 检测中东呼吸综合征冠状病毒的引物探针混合液及试剂盒 | |
| US11047011B2 (en) | Immunorepertoire normality assessment method and its use | |
| US8993332B2 (en) | Method for characterising the biological activity of helminth eggs, in particular Trichuris eggs | |
| CN109072205A (zh) | 核酸的检测 | |
| JP6083559B2 (ja) | 細胞運命の修飾因子を同定および検証するための方法および組成物 | |
| TW201713775A (zh) | 用於自複雜的異源群集中分析微生物品系、預測及識別其機能性關係及交互作用，且依據前述選擇並合成微生物系集之方法、裝置及系統 | |
| Eisenberg et al. | Bone marrow cells transdifferentiate to cardiomyocytes when introduced into the embryonic heart | |
| WO2022147239A1 (en) | High-spatial-resolution epigenomic profiling | |
| Li et al. | Gene expression profiles in mouse urethral development | |
| Carrau et al. | Changes in saliva and serum analytes in domestic pigs and wild boar experimentally infected with African swine fever virus | |
| CN105308188B (zh) | 方法、自我复制载体、测定试剂盒及分析装置 | |
| Praveena et al. | Detection of rabies virus genes by in-situ polymerase chain reaction | |
| US20220136074A1 (en) | Isothermal amplification and ambient visualization in a single tube for the detection of sars-cov-2 using loop-mediated amplification and crispr technology | |
| McGrath et al. | Aberrant extracellular matrix and cardiac development in models lacking the PR-DUB component ASXL3 | |
| Sweeten et al. | Brief report: low rates of herpesvirus detection in blood of individuals with autism spectrum disorder and controls | |
| CN113278616A (zh) | 可特异性识别刚地弓形虫具有RNA切割功能的DNAzyme及试剂盒 | |
| KR102291584B1 (ko) | 반려동물 및 가축의 질병진단을 위한 분자진단 방법 | |
| US20250236905A1 (en) | CARPOOL: A High Throughput in Vitro and in Vivo Screening Platform | |
| JP5743784B2 (ja) | Ｒｎａ検出用試薬およびｒｎａ検出方法 | |
| CN111239089B (zh) | 无损分析间充质干细胞膜蛋白的方法 | |
| Delgado et al. | G1 Phase Lengthening During Neural Tissue Development Involves CDC25B Induced G1 Heterogeneity | |
| KR20240072317A (ko) | 3세대 염기서열분석 기반 한탄바이러스 검출 방법 | |
| HK1147113B (en) | Method for characterising the biological activity of trichuris eggs |